Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g Vct5 Regulatory News (MIG5)

Share Price Information for Maven I&g Vct5 (MIG5)

Share Price is delayed by 15 minutes
Get Live Data
28.80    0.00 (0.00%)
Bid:
27.80
Ask:
29.80
Spread: 2.00 (7.194%)
Market Cap: £76.28m
MIG5 Live PriceLast checked at - London Stock Exchange

Intraday Maven I&g Vct5 Share Chart

Statement re NAV and Interim Dividend

5 Jul 2024 12:38

RNS Number : 3608V
Maven Income and Growth VCT 5 PLC
05 July 2024
 

Maven Income and Growth VCT 5 PLC

 

Unaudited Net Asset Value (NAV) and Interim Dividend

 

The Directors of Maven Income and Growth VCT 5 PLC (the Company) confirm that the unaudited NAV of the Company as at 31 May 2024 was 32.09p per Ordinary Share and that it reflects the payment, on 3 May 2024, of the final dividend of 1.10p per Ordinary Share in respect of the year ended 30 November 2023.

 

As Shareholders will be aware from recent Annual and Interim Reports, the decisions on distributions take into consideration a number of factors, including the realisation of capital gains, the adequacy of distributable reserves, the availability of surplus revenue and the VCT qualifying level, all of which are kept under close and regular review. The Board and the Manager recognise the importance of tax-free distributions to Shareholders and, subject to the conditions set out above, will seek, as a guide, to pay an annual dividend that represents 5% of the NAV per share at the preceding year end. It should be noted that the effect of paying dividends is to reduce the NAV of the Company by the total cost of the distribution.

 

The Board is pleased to declare that an interim dividend in respect of the year ending 30 November 2024, of 1.00p per Ordinary Share, will be paid on 6 September 2024 to Shareholders on the register at close of business on 9 August 2024. Since the Company's launch, and after receipt of this interim dividend, a total of 53.00p per Ordinary Share will have been distributed in tax-free dividends.

 

Dividend Investment Scheme (DIS)

The Company has in place a DIS, through which Shareholders may elect to have their dividend payments used to subscribe for new Ordinary Shares issued by the Company under the standing authority granted by Shareholders at Annual General Meetings. Shares issued under the DIS should qualify for VCT tax relief applicable for the tax year in which they are allotted, subject to an individual Shareholder's particular circumstances. 

 

Shareholders can elect to participate in the DIS in respect of future dividends, including the interim dividend, which is due to be paid on 6 September 2024, by completing a DIS mandate, which must be received by the Registrar (The City Partnership) before 23 August 2024, this being the next dividend election date. The mandate form, terms & conditions and full details of the scheme (including tax considerations) are available from the Company's website at: mavencp.com/migvct5. Election to participate in the DIS can also be made through the Registrar's online investor hub at: maven-cp.cityhub.uk.com/login.

 

Further to the information disclosed above, the Directors confirm that they are satisfied that all inside information (as defined by Article 7 of the Market Abuse Regulation (596/2014/EU)) that the Directors and the Company may have in their possession relating to the Company during the 30 day closed period leading up to the announcement of its interim results for the six months ended 31 May 2024 has been, or will be, notified to a regulatory information service.

 

Issued on behalf of the Board

Maven Capital Partners UK LLP

Secretary

5 July 2024

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVFLFVLDRIEIIS
Date   Source Headline
16th Apr 201411:49 amRNSDirector Declaration
7th Apr 20144:19 pmRNSOffer for Subscription - Supplementary Prospectus
7th Apr 201411:32 amRNSIssue of Equity
18th Mar 20147:00 amRNSOffer for Subscription - Supplementary Prospectus
3rd Mar 20144:13 pmRNSAnnual Financial Report
13th Feb 201410:57 amRNSDirector/PDMR Shareholding
13th Feb 201410:55 amRNSDirector/PDMR Shareholding
13th Feb 201410:47 amRNSDirector/PDMR Shareholding
10th Feb 20146:04 pmRNSOffer for Subscription - Supplementary Prospectus
5th Feb 20144:22 pmRNSIssue of Equity
3rd Feb 20145:23 pmRNSStatement re NAV and Offer for Subscription (Repla
27th Jan 20145:00 pmRNSStatement re NAV, Dividend and Offer
27th Nov 20132:07 pmRNSResult of General Meeting
24th Oct 20136:09 pmRNSOffer for Subscription
15th Oct 20135:10 pmRNSTransaction in Own Shares
11th Oct 20135:12 pmRNSInterim Management Statement
11th Oct 201312:18 pmRNSDirectorate Change
10th Oct 201311:02 amRNSNet Asset Value(s)
9th Oct 201311:09 amRNSNet Asset Value(s)
8th Oct 20131:49 pmRNSNet Asset Value(s)
7th Oct 201312:35 pmRNSNet Asset Value(s)
4th Oct 20132:12 pmRNSNet Asset Value(s)
3rd Oct 20132:36 pmRNSNet Asset Value(s)
2nd Oct 201312:21 pmRNSNet Asset Value(s)
1st Oct 201312:27 pmRNSNet Asset Value(s)
30th Sep 20132:43 pmRNSNet Asset Value(s)
27th Sep 201312:04 pmRNSNet Asset Value(s)
26th Sep 201311:57 amRNSNet Asset Value(s)
25th Sep 201312:22 pmRNSNet Asset Value(s)
25th Sep 201311:39 amRNSStatement re Proposed Joint Fund Raising
24th Sep 201311:52 amRNSNet Asset Value(s)
23rd Sep 201311:47 amRNSNet Asset Value(s)
20th Sep 20132:15 pmRNSNet Asset Value(s)
19th Sep 20131:05 pmRNSNet Asset Value(s)
18th Sep 201310:16 amRNSNet Asset Value(s)
17th Sep 201310:38 amRNSNet Asset Value(s)
16th Sep 201311:35 amRNSNet Asset Value(s)
13th Sep 201311:25 amRNSNet Asset Value(s)
12th Sep 201311:09 amRNSNet Asset Value(s)
11th Sep 201312:26 pmRNSNet Asset Value(s)
10th Sep 201312:22 pmRNSNet Asset Value(s)
9th Sep 20131:41 pmRNSNet Asset Value(s)
6th Sep 201311:44 amRNSNet Asset Value(s)
5th Sep 20131:14 pmRNSDirector Declaration
5th Sep 201312:33 pmRNSNet Asset Value(s)
4th Sep 20131:37 pmRNSNet Asset Value(s)
3rd Sep 201310:50 amRNSNet Asset Value(s)
2nd Sep 201311:17 amRNSNet Asset Value(s)
30th Aug 201312:30 pmRNSNet Asset Value(s)
29th Aug 201310:56 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.